Publications by authors named "Julia Dinger"

Claim this Profile
C
CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an Liver-on-Chip Model.
Nancy Blaurock-Möller, Marko Gröger, Fatina Siwczak, Julia Dinger, Diana Schmerler

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model.
Marko Gröger, Knut Rennert, Benjamin Giszas, Elisabeth Weiß, Julia Dinger

Sci Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of Cell Structure, Metabolism, and Biotransformation Activity of Liver-On-Chip Organ Models by Hypothermic Storage.
Marko Gröger, Julia Dinger, Michael Kiehntopf, Frank T Peters, Ursula Rauen

Adv Healthc Mater· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach.
Julia Dinger, Markus R Meyer, Hans H Maurer

Arch Toxicol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model.
Marko Gröger, Knut Rennert, Benjamin Giszas, Elisabeth Weiß, Julia Dinger

Sci Rep· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.
Julia Dinger, Campbell Woods, Simon D Brandt, Markus R Meyer, Hans H Maurer

Toxicol Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microfluidically perfused three dimensional human liver model.
Knut Rennert, Sandra Steinborn, Marko Gröger, Birgit Ungerböck, Anne-Marie Jank, Julia Dinger

Biomaterials· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
Markus R Meyer, Sandra Mauer, Golo M J Meyer, Julia Dinger, Birgit Klein

Drug Test Anal· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse.
Julia Dinger, Markus R Meyer, Hans H Maurer

Toxicol Lett· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
Julia Dinger, Markus R Meyer, Hans H Maurer

Anal Bioanal Chem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
Markus R Meyer, Julia Dinger, Andrea E Schwaninger, Dirk K Wissenbach, Josef Zapp

Anal Bioanal Chem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis